Pharma Archives - Page 2 of 83 - Boston Life Sciences Times

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

November 25, 2025

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

THIS WEEK'S STORIES

beBright Names Kyle Clay Chief Executive Officer to Lead Next Phase of Integrated Growth

November 21, 2025

Daniel Snyder, PhD Joins Propel Health Medical Affairs as Executive Vice President

November 24, 2025

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

November 25, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

AstraZeneca’s IMFINZI Gets First U.S. Approval for Perioperative Use in Early Gastric and GEJ Cancers

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

PharmaEssentia Highlights Publication of Phase 3 SURPASS-ET Trial Results in The Lancet Haematology

Most Read

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer

EDITOR PICKS

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

THIS WEEK'S STORIES

beBright Names Kyle Clay Chief Executive Officer to Lead Next Phase of Integrated Growth

Daniel Snyder, PhD Joins Propel Health Medical Affairs as Executive Vice President

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

POPULAR CATEGORY

ABOUT US

FOLLOW US